Guidance

Prostate specific antigen testing: summary guidance for GPs

This information aims to support GPs to give clear and balanced advice to men without symptoms of prostate disease who ask about PSA testing.

Documents

Details

This prostate cancer risk management programme (PCRMP) document helps GPs give clear and balanced information to men without symptoms of prostate disease who ask about prostate specific antigen (PSA) testing.

The PSA test is available free to any man aged 50 and over who requests it. It is available to anyone with a prostate, including trans women and non-binary people.

GPs should not proactively raise the issue of PSA testing with asymptomatic individuals. Prostate cancer is common and may not cause symptoms or shorten life.

GPs should follow NICE guideline [NG12] Suspected cancer: recognition and referral when managing men who have symptoms of prostate disease.

Published 1 January 2009
Last updated 13 May 2022 + show all updates
  1. Guidance updated to align with latest evidence, NICE guidance and updated PCRMP information for asymptomatic men aged 50 and over.

  2. Updated guidance.

  3. This summary information sheet for GPs is updated as part of the revised prostate cancer risk management programme materials published in March 2016

  4. First published.